Quinazoline and Quinoline Derivatives
Quinazolines and quinolines are nitrogen-containing heterocyclic compounds with aromatic structures that play a key role in the synthesis of drugs with anticancer, antimicrobial, and anti-inflammatory activity. Their derivatives feature structural modifications that optimise bioavailability and selectivity, enabling the development of new active ingredients for various therapeutic applications. These compounds are used in the manufacture of APIs for the treatment of cancer, infections, neurodegenerative diseases, and cardiovascular conditions. Additionally, quinazoline and quinoline derivatives are essential in the research of enzyme inhibitors and the design of innovative bioactive molecules.
At CymitQuimica, we offer high-purity quinazoline and quinoline derivatives for applications in chemical synthesis, pharmaceutical development, and biotechnology.
Found 65541 products of "Quinazoline and Quinoline Derivatives"
Sort by
Purity (%)
0
100
|
0
|
50
|
90
|
95
|
100
Ibrutinib
CAS:Controlled Product<p>Applications Ibrutinib is a highly selective Bruton’s tyrosine kinase (Btk) irreversible inhibitor.<br>References MacGlashan, D., et. al.: Int. Immunol., 11, 475 (2011)<br></p>Formula:C25H24N6O2Color and Shape:Off-WhiteMolecular weight:440.50Methyl 2-(chloromethyl)-4-phenylquinoline-3-carboxylate hydrochloride
CAS:Purity:97%Molecular weight:348.22000122070312-(3-methoxyphenyl)-8-methylquinoline-4-carboxylic acid
CAS:Purity:95.0%Molecular weight:293.32199096679693-Amino-5-biphenyl-4-yl-thiophene-2-carboxylic acid methyl ester
CAS:Color and Shape:SolidMolecular weight:309.38000488281258-Chlorotheophylline
CAS:<p>Applications A stimulant drug. It can be used as a binding agent to form stable salts of pharmaceutical drugs.<br>References Lyles, M. et al.: J. Med. Chem. 44, 4650 (2001).<br></p>Formula:C7H7ClN4O2Color and Shape:WhiteMolecular weight:214.619-Piperazino Levofloxacin Impurity
CAS:Controlled Product<p>Applications A degradation product of Levofloxacin (L360000). Levofloxacin impurity.<br>References ierens, C., et al.: J. Pharm. Biomed. Anal., 22, 763 (2000), Kitade, T., et al.: Chem. Pharm. Bull., 51, 53 (2003), Liang, Y., et al.: Anal. Chim. Acta, 510, 21 (2004),<br></p>Formula:C18H20FN3O4Color and Shape:NeatMolecular weight:361.368N-(2,6-Dichlorophenyl)-carbonimidic Dichloride
CAS:Controlled Product<p>Stability Moisture Sensitive<br>Applications N-(2,6-dichlorophenyl)-carbonimidic Dichloride is an impurity of clonidine (C587130). Chlonidine is α2-Adrenergic agonist. Antihypertensive; analgesic for neuropathic pain.<br>References Roach, A.G., et al.: J. Pharmacol. Exp. Ther., 227, 421 (1983), Glassman, A.H., et al.: Science, 226, 864 (1984), Abounassif, A.M., et al.: Anal. Profiles Drug Subs. Excip., 21, 109 (1992),<br></p>Formula:C7H3Cl4NColor and Shape:NeatMolecular weight:242.922-[5-amino-3-(2-furyl)-1H-pyrazol-1-yl]-6-isopropylpyrimidin-4(3H)-one
CAS:Purity:95.0%Molecular weight:285.30700683593755,6-Dihydro Tofacitinib
CAS:Controlled Product<p>Applications 5,6-Dihydro CP-690550 is an impurity of CP-690550 (C781350), a pyrrolo[2,3-d]pyrimidine derivative, as Janus kinase inhibitor for treatment of rheumatoid arthritis.<br>References Sheiner, L., et al.: Clin. Pharmacol. Ther., 25, 358 (1979); Dayneka, N., et al.: J. Pharmacokin. Biopharm., 21, 457 (1993); Changelian, P., et al.: Science, 302, 875 (2003); Lee, H., et al.: Clin. Pharmacol. Ther., 73, 348 (2003); Hutmacher, M., et al.: J. Clin. Pharmacol., 47, 238 (2007)<br></p>Formula:C16H22N6OColor and Shape:NeatMolecular weight:314.39Lornoxicam
CAS:Controlled Product<p>Applications Cyclooxygenase inhibitor; structurally similar to Tenoxicam. Anti-inflammatory; analgesic.<br> Not a dangerous good if item is equal to or less than 1g/ml and there is less than 100g/ml in the package<br>References Ankier, S.I., et al.: Postgrad. Med. J., 64, 752 (1988), Tricerri, M., et al.: Chem. Phys. Lipids, 71, 61 (1994), Santos, N., et al.: Biochemistry, 37, 8674 (1998), Pellicano, A., et al.: Infect. Immun., 75, 1738 (2007),<br></p>Formula:C13H10ClN3O4S2Color and Shape:Yellow Crystalline PowderMolecular weight:371.821-piperazine-1-yl-isoquinoline
CAS:Purity:95.0%Color and Shape:SolidMolecular weight:213.283996582031251,1’-[(1-Methylethyl)imino]bis[3-[4-(2-methoxyethyl)phenoxy]-2-propanol(Mixture of Diastereomers)
CAS:Controlled Product<p>Impurity Metoprolol EP Impurity O<br>Applications 1,1’-[(1-Methylethyl)imino]bis[3-[4-(2-methoxyethyl)phenoxy]-2-propanol (Metoprolol EP Impurity O) is an impurity of Metoprolol.<br>References Gyllenhaal, O., et al.: J. Biochem. Biophys. Methods, 43, 135 (2000), Chester, T., et al.: Anal. Chem., 74, 2801 (2002),<br></p>Formula:C27H41NO6Color and Shape:NeatMolecular weight:475.62(Z)-2-(5-Fluoro-2-methyl-1-(4-(methylsulfinyl)benzylidene)-1H-inden-3-yl)acetic acid
CAS:Purity:95.0%Color and Shape:SolidMolecular weight:356.4100036621094N-Nitroso Clonidine
CAS:Controlled ProductFormula:C9H8Cl2N4OColor and Shape:NeatMolecular weight:259.092-(1-Amino-2-methylpropyl)-3-benzyl-7-chloroquinazolin-4(3H)-one
CAS:Purity:98%Molecular weight:341.8399963378906Dehydro Nifedipine-d6
CAS:Controlled Product<p>Applications The main labelled Nifedipine metabolite in human plasma.<br>References Guengerich, F., et al.: J. Biol. Chem., 261, 5051 (1986), Bork, R., et al.: J. Biol. Chem., 264, 910 (1989), Kerla, V., et al.: Biochem. Pharmacol., 44, 1745 (1992),<br></p>Formula:C17H10D6N2O6Color and Shape:NeatMolecular weight:350.36Etomidate
CAS:Controlled Product<p>Applications Etomidate is a hypnotic. Neuroprotective & Neuroresearch Products<br> Not a dangerous good if item is equal to or less than 1g/ml and there is less than 100g/ml in the package<br>References Goetz, E., et al.: Anaesthesist, 23, 331 (1974), Chang, Z. L., et al.: Anal. Profiles Drug Subs., 12, 191 (1983),<br></p>Formula:C14H16N2O2Color and Shape:Off-WhiteMolecular weight:244.292-Hydroxy-5-methylpyridine
CAS:Controlled Product<p>Applications 2-Hydroxy-5-methylpyridine (cas# 1003-68-5) is a useful compound for organic synthesis. In particular it has been used for the diastereoselective preparation of cyclobutane-fused pyridinyl sulfonyl fluorides.<br>References Liu, J., et al.: Org. Biomol. Chem., 18, 4019 (2020)<br></p>Formula:C6H7NOColor and Shape:Light YellowMolecular weight:109.132-Nitrobenzaldehyde
CAS:<p>Applications 2-Nitrobenzaldehyde is a benzaldhyde with a nitro group substituted in the ortho position. 2-Nitrobenzaldehyde is used in the preparation of dyes and colorants such as Indigo carmine. 2-Nitrobenzaldehyde gas been shown to be a useful photoremovable protecting group as well as in the preparation of more effective ones such as o-Nitrophenylethylene glycol.<br>References Gravel, D. et al.: Can. J. Chem., 61, 400 (1983); Sebej, P. et al.: J. Org. Chem., 74, 8647 (2009); Das, A. et al.: J. Ind. Che,. Soc., 49, 993 (1972);<br></p>Formula:C7H5NO3Color and Shape:NeatMolecular weight:151.121,2,3,4-Tetrahydro-4,8-dihydroxy-2-methyl-isoquinoline
CAS:<p>Impurity Phenylephrine 4,6-DMTQ Impurity (Peak-2)<br>Applications Product formed during the decomposition of Phenylephrine<br>References Millard, B., et al.: J. Pharm. Pharmacol., 25, 24 (1973),<br></p>Formula:C10H13NO2Color and Shape:Light YellowMolecular weight:215.68(R)-9-Hydroxy Risperidone-d4
CAS:Controlled ProductFormula:C23H23D4FN4O3Color and Shape:NeatMolecular weight:430.512-(2-methoxyphenyl)-8-methylquinoline-4-carboxylic acid
CAS:Purity:95.0%Molecular weight:293.32199096679696-chloro-2-pyridin-4-ylquinoline-4-carboxylic acid
CAS:Purity:95.0%Molecular weight:284.700012207031252-(Aminomethyl)-1-ethylpyrrolidine
CAS:Controlled ProductFormula:C7H16N2Color and Shape:Colourless To Light YellowMolecular weight:128.22Ramelteon Metabolite M-II-d3 (mixture of R and S at the hydroxy position)
CAS:Controlled Product<p>Applications The major metabolite of Ramelteon in serum (M-II).<br>References Karim, A., et al.: J. Clin. Pharmacol., 44, 1210 (2004), Prescott, E., et al.: Drug Metab. Rev., 36, 203 (2004), Kato, K., et al.: Neuropharmacology, 48, 301 (2005), Karim, A., et al.: J. Clin. Pharmacol., 46, 140 (2006),<br></p>Formula:C16D3H18NO3Color and Shape:NeatMolecular weight:278.36Mitotane-13C6
CAS:Controlled Product<p>Applications Mitotane-13C6 is the isotope labelled analogue of Mitotane (M372500), an antineoplastic and adrenolytic agent.<br>References Das, S., and Thomas, P.: Endocrinology, 140, 1953 (1999), Andersen, A., et al.: Ther. Drug. Monit., 21, 355 (1999), Leblond, V.S., and Hontela, T.: Toxicol. Appl. Pharmacol., 157, 16 (1999)<br></p>Formula:C6C8H10Cl4Color and Shape:Light YellowMolecular weight:326.06-O-α-D-Maltosyl-β-cyclodextrin
CAS:<p>Applications 6-O-α-D-Maltosyl-β-cyclodextrin is an additive to improve the solubility of quetiapine.<br>References Ogawa, N., et. al.: Chem. Pharm. Bull., 31, 809 (2013)<br></p>Formula:C54H90O45Color and Shape:White PowderMolecular weight:1459.262-[2-[[4-[(5S)-5-[[[(5-Chloro-2-thienyl)carbonyl]amino]methyl]-2-oxo-3-oxazolidinyl]phenyl]amino]ethoxy]-acetic Acid Hydrochloride
CAS:Controlled Product<p>Stability Hygroscopic<br>Applications 2-[2-[[4-[(5S)-5-[[[(5-chloro-2-thienyl)carbonyl]amino]methyl]-2-oxo-3-oxazolidinyl]phenyl]amino]ethoxy]-acetic Acid Hydrochloride is a metabolite of Rivaroxaban (R538000) which is a novel antithrombotic agent. Rivaroxaban is also a highly potent and selective, direct FXa inhibitor.<br>References Ansell, J., et al.: Drugs, 64, 1 (2004), Eriksson, B., et al.: J. Thromb. Haemost., 3, 103 (2005), Kubitza, D., et al.: Clin. Pharmacol. Ther., 78, 412 (2005)<br></p>Formula:C19H20ClN3O6S·HClColor and Shape:White Light RedMolecular weight:453.903646N-Formyl Mirabegron
CAS:Controlled ProductFormula:C22H24N4O3SColor and Shape:NeatMolecular weight:424.516Perphenazine-d4 (phenothiazine-1,3,7,9-d4)
CAS:Controlled Product<p>Applications Perphenazine-d4 (phenothiazine-1,3,7,9-d4) (CAS# 155593-75-2) is a useful isotopically labeled research compound.<br></p>Formula:C21D4H22ClN3OSColor and Shape:NeatMolecular weight:407.992-(2-Chlorophenyl)quinoline-4-carboxylic acid
CAS:Color and Shape:SolidMolecular weight:283.70999145507812-Amino-5-bromo-N-cyclohexyl-N-methylbenzylamine Dihydrochloride
CAS:Controlled Product<p>Impurity Bromhexine EP Impurity D<br>Applications 2-Amino-5-bromo-N-cyclohexyl-N-methylbenzylamine (Bromhexine EP Impurity D) is an impurity of Bromhexine hydrochloride (B678600). Bromhexine hydrochloride impurity D.<br>References Uboh, C.E., et al.: J. Pharmaceut. Biomed. Anal., 9, 33 (19991),<br></p>Formula:C14H21BrN2·2ClHColor and Shape:Light YellowMolecular weight:370.16((3S,4R)-4-(4-Fluorophenyl)piperidin-3-yl)methanol
CAS:Controlled Product<p>Applications ((3s,4r)-4-(4-Fluorophenyl)Piperidin-3-Yl)Methanol (cas# 125224-43-3) is a useful research chemical.<br></p>Formula:C12H16FNOColor and Shape:Light YellowMolecular weight:209.26Alogliptin Benzoate
CAS:<p>Applications Alogliptin Benzoate is an oral antihyperglycemic agent that is a selective inhibitor of the enzyme dipeptidyl peptidase-4 (DPP-4). Alogliptin Benzoate is used in the treatment of type 2 diabetes.<br>References Wang, Y., et. al.: Drugs Future, 33, 7 (2008); Lynn, F., et al.: Diabetes, 50, 1004 (2001); Trumper, A., et al.: J. Endocrinol., 174, 233 (2002); Vollmer, K., et al.: J. Clin. Endocrinol. Metab., 94, 1379 (2009)<br></p>Formula:C18H21N5O2·C7H6O2Color and Shape:NeatMolecular weight:461.51Everolimus-d4 (>85%)
CAS:Controlled Product<p>Applications Macrolide immunosuppressant; derivative of Rapamycin. Inhibits cytokine-mediated lymphocyte proliferation.<br> Not a dangerous good if item is equal to or less than 1g/ml and there is less than 100g/ml in the package<br>References Dumont, F.J., et al.: Curr. Opin. Invest. Drugs, 2, 1220 (2001), Kovarik, J. M., et al.: Clin. Pharmacol. Ther., 69, 48 (2001), Nashan, B., et al.: Ther. Drug Monit., 24, 53 (2002),<br></p>Formula:C532H4H79NO14Purity:>85%Color and Shape:White To Light YellowMolecular weight:962.25Omeprazole-d3 Sulfone
CAS:Controlled ProductFormula:C17H16D3N3O4SColor and Shape:NeatMolecular weight:364.43N-(4-Pyridin-2-yl-thiazol-2-yl)benzene-1,4-diamine
CAS:Color and Shape:SolidMolecular weight:268.33999633789067-Hydroxy Risperidone
CAS:Controlled ProductFormula:C23H27FN4O3Color and Shape:NeatMolecular weight:426.48Doravirine
CAS:<p>Applications Doravirine is a novel non-nucleoside inhibitor of HIV-1 reverse transcriptase with potent activity against wild-type virus.<br>References Feng, M., et al.: Antimicrob Agents Chemother, 60, 2241-7 (2016); Lai, M.T., et al.: Antimicrob Agents Chemother, 58, 1652-63 (2014); Anderson, M.S., et al.: Antivir Ther., 20, 397-405 (2015);<br></p>Formula:C17H11ClF3N5O3Color and Shape:NeatMolecular weight:425.753,4-Dihydro-7-hydroxyquinoline-2(1H)-one
CAS:Formula:C9H9NO2Color and Shape:NeatMolecular weight:163.17Azasetron-d3 Hydrochloride
CAS:Controlled Product<p>Applications A 5-HT3 receptor antagonist. Used as an antiemetic.<br>References Sato, N., et al.: Japan J. Pharmacol., 59, 443 (1992), Haga, K., et al.: Japan J. Pharmacol., 63, 377 (1993)<br></p>Formula:C172H3H17ClN3O3·ClHColor and Shape:NeatMolecular weight:389.29Sitagliptin Monohydrochloride Monohydrate
CAS:<p>Applications Sitagliptin Monohydrochloride Monohydrate has therapeutic applications and is used in pharmaceutical compositions in the form of immediate release tablets.<br>References Arroyo Hidalgo, S., & Pladevall Roses, M.: PCT Int. Appl. (2015), WO 2015114152 A1<br></p>Formula:C16H15F6N5O·HCl·H2OColor and Shape:NeatMolecular weight:407.31 + 36.46 + 18.023-acetyl-6-chloro-4-(4-fluorophenyl)quinolin-2(1H)-one
CAS:Purity:95.0%Molecular weight:315.7300109863281Thiophene, 2,2′,2′′,2′′′-(1,2-ethenediylidene)tetrakis-
CAS:Purity:98%Molecular weight:356.53Tolcapone
CAS:Controlled Product<p>Applications Orally active inhibitor of central and peripheral catechol-O-methyltransferase (COMT). Antiparkinsonian.<br>References Dingemanse, J., et al.: Clin. Pharmacol. Ther., 57, 508 (1995), Keating, K.A., Drugs, 19, 165 (2005),<br></p>Formula:C14H11NO5Color and Shape:ColourlessMolecular weight:273.246-Hydroxy-2-mercaptobenzimidazole
CAS:Controlled ProductFormula:C7H6N2OSColor and Shape:NeatMolecular weight:166.20N-(3-Bromophenyl)-6,7-dimethoxyquinazolin-4-amine hydrochloride
CAS:Purity:95.0%Molecular weight:396.6700134277344Mirtazapine-d4
CAS:Controlled Product<p>Applications Mirtazapine-d4 is the labeled analogue of Mirtazapine (M365000), which is an α2-Adrenergic blocker, analogue of Mianserin, and antidepressant.<br>References De Boer, T., et al.: Neuropharmacology, 27, 399 (1988), Smith, W.T., et al.: Psychopharmacol. Bull., 26, 191 (1990);<br></p>Formula:C17H15D4N3Color and Shape:White To Light YellowMolecular weight:269.385-chloro-2-(1H-pyrazol-5-yl)aniline
CAS:Purity:95.0%Color and Shape:SolidMolecular weight:193.6300048828125Oxyphenbutazone-d9
CAS:Controlled ProductFormula:C192H9H11N2O3Color and Shape:BeigeMolecular weight:333.43Decloxizine Dihydrochloride
CAS:Controlled Product<p>Impurity Hydroxyzine EP Impurity B<br>Applications Decloxizine Dihydrochloride (Hydroxyzine EP Impurity B) is a Hydroxyzine (H996500) impurity.<br>References Lulling, J., et al.: Medicina Pharmacol. Exp., 16 48 (1967),<br></p>Formula:C21H28N2O2·2ClHColor and Shape:NeatMolecular weight:413.381-(4-Methoxybenzyl)-4-oxo-1,4-dihydroquinoline-3-carboxylic acid
CAS:Purity:95.0%Molecular weight:309.3210144042969(-)-trans-Phenothrin
CAS:<p>Applications (-)-trans-Phenothrin is used in exhaustive parallel conformational search of pyrethroids and structural similarity study. Also used as an active compound combination having insecticidal properties, a synthetic reagent in the preparation and optical purity of benzylic ester pyrethroid enantiomers.<br> Not a dangerous good if item is equal to or less than 1g/ml and there is less than 100g/ml in the package<br>References Bertok, B., et al.: J. Environ. Sci. Health, Part B., 31, 495 (1996); Chuman, H., et al.: Journal of Chemical Software, 4, 143 (1998); Thielert, W., et al.: PCT Int. Appl. (2015), WO 2015132140 A1 20150911;<br></p>Formula:C23H26O3Color and Shape:Colourless To YellowMolecular weight:350.45Gefitinib-d3
CAS:Controlled Product<p>Applications Labelled Gefitinib (G304000). Gefitinib is an antineoplastic.<br>References Anderson, N.G., et al.: Int. J. Cancer, 94, 774 (2001), Hirata, A., et al.: Cancer Res., 62, 2554 (2002), Kris, M.G., et al.: J. Am. Med. Assoc., 290, 2149 (2003), Tamura, K., et al.: Expert Opin. Pharmacother., 6, 985 (2005),<br></p>Formula:C22H21D3ClFN4O3Color and Shape:NeatMolecular weight:449.92N-(2-Aminoethyl)morpholine
CAS:Formula:C6H14N2OPurity:98%Color and Shape:Solidified mass or fragmentsMolecular weight:130.1911,4-bis[3,4-dihydro-2(1H)-quinolinon-7-oxy]butane
CAS:Controlled Product<p>Impurity Aripiprazole Diquinoline Butanediol Impurity (USP)<br>Applications An impurity found in the process for the preparation of Aripiprazole (A771000). Aripiprazole Diquinoline Butanediol Impurity (USP).<br>References Burris, K., et al.: J. Pharmacol. Exp. Ther., 302, 381 (2002), Harrison, T., et al.: Drugs, 64, 1715 (2004),<br></p>Formula:C22H24N2O4Color and Shape:Off-WhiteMolecular weight:380.44cis-[2-(2,4-Dichlorophenyl)-2-(1H-imidazol-1-ylmethyl)-1,3-dioxolan-4-yl]methyl p-Tolylsulfonate
CAS:<p>Impurity Ketoconazole EP Impurity E<br>Applications cis-[2-(2,4-Dichlorophenyl)-2-(1H-imidazol-1-ylmethyl)-1,3-dioxolan-4-yl]methyl p-Tolylsulfonate (Ketoconazole EP Impurity E) is an intermediate in the synthesis of the drug Ketoconazole (K186000).<br>References McManus, O., et al.: Biochemistry, 32, 6128 (1993), Olesen, S., et al.: Eur. J. Pharmacol., 251, 53 (1994), Assano, M., et al.: J. Pharm. Exp. Ther., 275, 775 (1995), Hewawasam, P., et al.: J. Med. Chem., 45, 1487 (2002),<br></p>Formula:C21H20Cl2N2O5SColor and Shape:NeatMolecular weight:483.365-(4-Trifluoromethyl-phenyl)-thiophene-2-carbaldehyde
CAS:Formula:C12H7F3OSPurity:95.0%Color and Shape:SolidMolecular weight:256.24ORM-15341
CAS:<p>Applications ORM-15341 is a metabolite of Darolutamide. Darolutamide is a potent androgen receptor antagonist with strong efficacy in prostate cancer models.<br>References Sugawara, T., et al.: Int. J. Cancer, 145, 1382 (2019); Yu, J., et al.: Eur. J. Med. Chem., 182, 111608 (2019)<br></p>Formula:C19H17ClN6O2Color and Shape:NeatMolecular weight:396.83Nordeprenyl (>90%)
CAS:Controlled Product<p>Applications A metabolite of Deprenyl.<br>References Yoshida, T., et al.: Xenobiotica, 17, 957 (1987), Meeker, J., et al.: J. Anal. Toxicol., 14, 330 (1990), Heinonen, E., et al.: Clin. Pharm. Ther., 56, 742 (1994), Szoko, E., et al.: Int. J. Pharm. Adv., 1, 320 (1996),<br></p>Formula:C12H15NPurity:>90%Color and Shape:NeatMolecular weight:173.25L-2-Aminobutyric Acid Methyl Ester Hydrochloride
CAS:Controlled Product<p>Applications Intermediate in the preparation of Ergonovine (E597800) derivatives.<br>References Beck, H., et al.: Bioorg. Med. Chem. Lett., 18, 1037 (2008),<br></p>Formula:C5H12ClNO2Color and Shape:NeatMolecular weight:153.612-Thiophenecarbonyl chloride
CAS:Formula:C5H3ClOSPurity:95%Color and Shape:LiquidMolecular weight:146.59TERT-BUTYL 3-(THIOPHEN-2-YL)PYRROLIDINE-1-CARBOXYLATE
CAS:Purity:95.0%Molecular weight:253.36000061035156N-pyridin-3-yl-2-(tetrahydro-2H-pyran-4-ylcarbonyl)hydrazinecarbothioamide
Molecular weight:280.3500061035156Retigabine
CAS:Controlled Product<p>Stability Hygroscopic<br>Applications A new experimental anticonvulsant drug. Anxiolytic.<br>References Dailey, J.W.; et al.: Neuroscience Lett., 195, 77 (1995), Korsgaard, M.P.G., et al.: J. Pharmacol. Exp. Ther., 314, 1, 282 (2005),<br></p>Formula:C16H18FN3O2Color and Shape:NeatMolecular weight:303.332-(4-morpholinyl)-8-quinolinol
CAS:Purity:95.0%Color and Shape:Liquid, OilMolecular weight:230.26699829101562Gabapentin Related Compound B
CAS:<p>Impurity Gabapentin EP Impurity B; Gabapentin USP Related Compound B<br>Applications Gabapentin Related Compound B (Gabapentin EP Impurity B; Gabapentin USP Related Compound B) is a Gabapentin analogue for treatment of neurological disorders.<br>References Sit, S., et al.: J. Med. Chem., 33, 2982 (1990), O'Brien, P., et al.: J. Med. Chem., 37, 1810 (1994), Bryans, J., et al.: Med. Res. Rev., 19, 149 (1999),<br></p>Formula:C9H13NO2Color and Shape:NeatMolecular weight:167.20[2'-(5-ethyl-3,4-diphenyl-pyrazol-1-yl)-biphenyl-3-yloxy]acetic acid
CAS:Purity:97.0%Color and Shape:SolidMolecular weight:474.55999755859375Niclosamide
CAS:Controlled Product<p>Applications Niclosamide is used as an anthelmintic drug (Cestodes).<br> Not a dangerous good if item is equal to or less than 1g/ml and there is less than 100g/ml in the package<br>References Loftsson, T., et al.: J. Pharm. Sci., 85, 1017 (1996), Malik, N., et al.: Anti. Cancer Drugs, 10, 767 (1999), El-Sayed, M., et al.: Pharm. Res., 18, 23 (2001),<br></p>Formula:C13H8Cl2N2O4Color and Shape:NeatMolecular weight:327.122-CHLORO-6-PYRIDINESULFONYL CHLORIDE
CAS:Formula:C5H3Cl2NO2SPurity:98%Color and Shape:SolidMolecular weight:212.045-(4-chlorophthalazin-1-yl)-N,2-dimethylbenzenesulfonamide
CAS:Purity:95.0%Molecular weight:347.82000732421875(S)-(-)-3-Acetylthio-2-methylpropionic Acid
CAS:Controlled Product<p>Applications S-Acetylthio-2-methylpropionic Acid (S-AMPA) is a key chiral intermediate for Captopril (C175750) and other hypertension drugs.<br> Not a dangerous good if item is equal to or less than 1g/ml and there is less than 100g/ml in the package<br>References Cushman, D., et al.: Biochem., 16, 5484 (1977), Ondetti, M., et al.: J. Med. Chem., 24, 355 (1981), Tseng, T., et al.: Cancer Lett., 62, 233 (1992),<br></p>Formula:C6H10O3SColor and Shape:ColourlessMolecular weight:162.21
![2-[5-amino-3-(2-furyl)-1H-pyrazol-1-yl]-6-isopropylpyrimidin-4(3H)-one](/_next/image/?url=https%3A%2Fstatic.cymitquimica.com%2Fproducts%2F10%2Fthumb-webp%2FF495925.webp&w=3840&q=75)
![1,1’-[(1-Methylethyl)imino]bis[3-[4-(2-methoxyethyl)phenoxy]-2-propanol(Mixture of Diastereomers)](/_next/image/?url=https%3A%2Fstatic.cymitquimica.com%2Fproducts%2FTR%2Fthumb-webp%2FM304900.webp&w=3840&q=75)
![2-[2-[[4-[(5S)-5-[[[(5-Chloro-2-thienyl)carbonyl]amino]methyl]-2-oxo-3-oxazolidinyl]phenyl]amino]e…](/_next/image/?url=https%3A%2Fstatic.cymitquimica.com%2Fproducts%2FTR%2Fthumb-webp%2FC421840.webp&w=3840&q=75)
![4-{6-Bromo-[1,2,4]triazolo[4,3-a]pyridin-3-yl}pyridine](/_next/image/?url=https%3A%2Fstatic.cymitquimica.com%2Fproducts%2F10%2Fthumb-webp%2FF214513.webp&w=3840&q=75)
![1,4-bis[3,4-dihydro-2(1H)-quinolinon-7-oxy]butane](/_next/image/?url=https%3A%2Fstatic.cymitquimica.com%2Fproducts%2FTR%2Fthumb-webp%2FB426500.webp&w=3840&q=75)
![cis-[2-(2,4-Dichlorophenyl)-2-(1H-imidazol-1-ylmethyl)-1,3-dioxolan-4-yl]methyl p-Tolylsulfonate](/_next/image/?url=https%3A%2Fstatic.cymitquimica.com%2Fproducts%2FTR%2Fthumb-webp%2FD435718.webp&w=3840&q=75)
![[2'-(5-ethyl-3,4-diphenyl-pyrazol-1-yl)-biphenyl-3-yloxy]acetic acid](/_next/image/?url=https%3A%2Fstatic.cymitquimica.com%2Fproducts%2F10%2Fthumb-webp%2FF049791.webp&w=3840&q=75)
![2-[5-(3-bromophenyl)-1H-pyrazol-3-yl]phenol](/_next/image/?url=https%3A%2Fstatic.cymitquimica.com%2Fproducts%2F10%2Fthumb-webp%2FF314704.webp&w=3840&q=75)
